Prenatal diagnosis of critical (requiring neonatal intervention) cardiac defects (critical congenital heart diseases (CCHD)) improves survival, yet detection of such malformations is poor. Our institution changed its practice and integrated a pediatric cardiologist into the perinatal team. The purpose of this study was to evaluate how this change affected the rate of detected congenital heart disease (CHD) and the diagnostic accuracy.
INTRODUCTION
The prenatal detection of congenital heart disease (CHD) in pregnancies at low risk for cardiac defects ranges from 5 to 40%. [1] [2] [3] Detection of CHD in the fetus can be improved, by obtaining additional views of the outflow tracts, 4 educating sonographers on the technique of fetal heart scanning 5 and performing detailed fetal echocardiography. 6 Prenatal detection of ''critical'' CHD (i.e., those defects requiring neonatal surveillance or intervention) is most valuable since it clearly improves postnatal outcomes. [7] [8] [9] The purpose of this study was to describe the rate of detected fetal critical CHD (CCHD) at a single institution over a 10-year period, and to examine how detection and diagnostic accuracy changed once a pediatric cardiologist was integrated into the perinatal team.
METHODS

Sample
Fetal anatomical surveys conducted between 16 and 40 weeks of gestation at a tertiary care perinatal center from 1991 to 2001 were reviewed and divided into two time periods based on separation (Time 1: July 1991 to August 1996) or integration (September 1996 to August 2001) of the pediatric cardiologist with the perinatal team. The study was approved by the Institutional Review Board.
Procedures
During both Times 1 and 2, referrals for ultrasound from a discreet geographical location of four counties in northeastern Illinois with combined populations of 4 to 4.5 million. The perinatal center had been established for 10 years before Time 1, and accepted referrals from 325 to 350 local obstetricians. The number of referring obstetricians were constant throughout the study period. Only one new insurance carrier was added (in 2001) during the 10-year period.
When an ultrasound was requested by the referring obstetrician, the MFM, on a rotating basis, reviewed each request. Based on maternal history, it was decided on a case-by-case basis what type of ultrasound exam should be performed: either an anatomical survey (Time 1) or anatomical survey plus fetal echocardiogram (Time 2). All anatomical surveys were performed by experienced obstetrical sonographers under the direct supervision of the MFM in the obstetrical suite. During Time 1 fetuses with traditional risk factors for CHD (maternal diabetes, family history of CHD, fetal noncardiac or chromosome anomaly, fetal arrhythmia or suspected CHD) underwent the same cardiac evaluation as those at low risk for CHD: two-dimensional (2-D) imaging of the four chambers, the right and left ventricular outflow tracts and the aortic arch. Fetuses with abnormal or suspicious cardiac views were referred to one of the three pediatric cardiologists for complete diagnosis and counseling. The pediatric cardiologist or pediatric echocardiography technician performed the fetal echocardiogram at a separate time and place from the obstetrical suite. The pediatric cardiologist gave the exact diagnosis, counseled the family as to the likely postnatal course, and outlined a plan for cardiology follow-up and neonatal intervention. The mother then returned to both the MFM and the pediatric cardiologist for continued care.
During Time 2, if the MFM decided, based on risk factors, that a fetal echocardiogram should be performed in addition to the anatomical survey, cardiac imaging of the fetus was directly supervised by a pediatric cardiologist integrated into the perinatal center. In addition to the basic cardiac views obtained during the anatomical survey, pulsed and color-flow Doppler techniques were utilized in the cardiac evaluation. This collaboration, which we called an ''integrated'' model of care, allowed for weekly one-onone interaction between the pediatric cardiologist, the MFM, and the obstetrical sonographer. If a cardiac anomaly was diagnosed during Time 2, the MFM and pediatric cardiologists counseled the family together, and any further testing, such as amniocentesis, was performed. A plan for the reminder of the pregnancy was jointly outlined during the first visit.
During the ten-year study period, there were no changes in obstetrical sonographers or MFM. At study onset (1991), sonographer experience ranged from 1 to 8 years (mean 5 years), and three of four MFM were 1 to 3 years postfellowship training. The four board-certified pediatric cardiologists (three in phase 1 and one in phase 2) completed their fellowships 18, 6, and 2 years prior to 1991, and 5 years prior to 1996.
All ultrasound examinations were performed on either the 128XP (1991 to 1997) or Sequoia (1998 to 2001) ultrasound platform (Acuson, Mountain View, CA) using 3.5 to 8 MHz transducers.
In order to exclude secular trends attributable to technologic advances in ultrasound that occurred between Times 1 and 2, the rate of suspected central nervous system and gastrointestinal abnormalities, including diaphragmatic hernia, gastroschisis, omphalocele, duodenal atresia and anencephaly, spina bifida, choroid plexus cysts, and hydrocephalus, were compared between Times 1 and 2.
Postnatal Follow-up Infants who had normal fetal echocardiograms were examined as newborns by their pediatrician in the nursery or within the first 2 weeks of life. Routine echocardiograms were not performed unless there was clinical suspicion of neonatal CHD, such as the presence of a murmur. Infants with suspected fetal CCHD defined as ductal-dependent lesions including single ventricle variants and defects with severe outflow tract obstruction; or conditions requiring neonatal intervention such as cardiomyopathy (Table 1) , were evaluated by postnatal echocardiography, cardiac catheterization, or autopsy.
Analysis
The rate of suspected noncardiac and CCHD per thousand scans and the numbers of defects seen on four-chamber vs outflow tract imaging was compared between the two time-periods. Differences in diagnostic accuracy, rate of detected critical CHD and gestational ages between the two time periods were evaluated by Fisher's exact test. A significance level of p<0.05 was used to evaluate all comparisons.
RESULTS
The number of fetal anatomic surveys increased from 3500 to 5133 between the two time periods. More CCHD, GI, and CNS abnormalities were suspected during Time 2, but did not differ significantly from the number of defects suspected during Time 1 (Table 2) . However, more of the CCHD suspected during Time 2 were confirmed to be true defects when compared with Time 1 (Table 3) . Detecting Fetal Heart Defects Cuneo et al.
During Time 1, 32 fetuses were suspected to have CCHD: eight were found to have normal hearts after birth, and 24 had true CCHD. The positive predictive value was 75%. Of the defects detected, 21% (5/24) were only noted in great vessel imaging. There was one false negative reported to the perinatal center during this time: a fetus from a low-risk pregnancy felt to be normal at 20 weeks in 1994 was found after birth to have ductal-dependent pulmonary stenosis with intact ventricular septum.
During the second time period of the study, CCHD were suspected in 69 fetuses (Table 2) . Three fetuses had suspected coarctation of the aorta due to significant size disproportion at the level of the great vessels at 22 to 25 weeks (the pulmonary valve annulus diameter >2 mm larger than the aortic valve annulus diameter), but all were found to be normal after birth. The remaining 66 fetuses had true CCHD, for a positive predictive value of 97%. In all, 18 fetuses (27%) had normal four-chamber views, with abnormalities detected only on great vessel evaluation. No missed diagnoses of CCHD were reported to the perinatal center during the second time period (Table 4) .
During Time 2, all but two fetuses with suspected CCHD were diagnosed by 2-D imaging alone. These two fetuses had abnormal right ventricles with turbulent and high-velocity color and pulsed Doppler flow across the ductus arteriosus, indicating severe constriction of that vessel resulting in severe right ventricular hypertension.
CCHD was detected and diagnosed more accurately during the second time period as compared to the first time period: the rate of detected CCHD increased from 6.8/1000 ultrasounds in Time 1 to 12.9/1000 ultrasounds in Time 2 (p ¼ 0.007) and the true positive rate was higher during Time 2 for the overall detection of CCHD (p ¼ 0.004) ( Table 1 ). There was no difference in fetal gestational age at the time of diagnosis: 24.8±4.8 weeks (Time 1) vs 24.1±5.1 weeks (Time 2) (p ¼ 0.48).
DISCUSSION
The most significant finding of this study, which describes a collaborative approach to the diagnosis of fetal CCHD, is that the rate of detected CCHD and the accuracy of antenatal diagnosis improved with the integration of a pediatric cardiologist into the perinatal team. Previous studies have also reported improvements in CHD detection and diagnosis and have attributed improvements to various factors. Some centers have reported a growing proportion of prenatal studies that are detecting CHD. 10 Others have noted changes in the type of CHD in liveborn children, suggesting that pregnancies with more serious defects may have been interrupted. 11 Finally, some have noted a greater proportion of fetuses with CHD in their referral population. 12 These authors have attributed the increases in prenatally detected CHD to advanced ultrasound technology, enhanced training of community sonographers, larger physician provider networks and increased education, expectations, and awareness of obstetric physicians. 13 No previous studies have evaluated the role of perinatal team membership in CCHD detection. The current study highlights the valuable role that a pediatric cardiologist can play as a member of the perinatal team. With integration of the pediatric cardiologist, there were significant improvements not only in the rate of CHD detection, but also the diagnostic accuracy of those CHD that were detected.
Along with the integration of the pediatric cardiologist, other factors including those listed above, [10] [11] [12] [13] may have contributed to the improved detection of CCHD found in our study. However, we believe these factors are limited. To control for changes in diagnostic accuracy, we compared number of suspected abnormal noncardiac and cardiac defects between the two time periods, and found no significant difference over time. Thus, although a similar number of CCHD were suspected in both time periods, more truly abnormal CCHD were detected during the second time period, implying that factors other than technical quality of the ultrasound were responsible for the increased number of true positives during Time 2. Similarly, because the gestational age at the time of CCHD detection did not change over time, nor did referrals specifically for cardiac evaluation, it is unlikely that more timely referrals by obstetricians could explain observed improvements. Lastly, although the referral network grew over time, this factor was not explanatory, given that we looked at the rate of detected CCHD per number of ultrasounds rather than the absolute number of cardiac defects. In the end, the current study supports the idea that improvements in CCHD detection and diagnostic accuracy occur through the frequent and repeated exposure of the obstetrical sonographers and the MFM to the pediatric cardiologist, and the collaborative learning that occurs through this interaction. It is noteworthy that although standards exist for performing fetal cardiac exams, traditionally the majority of obstetrical sonographers have limited exposure to pediatric cardiology.
There were some inherent limitations to the current study, namely, its retrospective nature and the inability to ascertain the true false negatives for each time period. However, because referrals to our perinatal center come from a limited geographic area, it is likely that missed diagnosis of major defects would be reported back to the perinatal center, as occurred during Time 1. Because we could not provide complete false-negative data, the positive predictive value and false-positive rates were compared between time periods, and found to be significantly different.
It has been suggested that the additional cost of performing fetal echocardiography on high-risk mothers may be a downside to the integration model described here. However, when screening for fetal cardiac defects, the cost to identify one fetus with CHD is much higher if the detection rate is low.
14 If the incidence of CHD is 8/1000, screening 10,000 mothers for CHD should detect 80 defects. The cost for those 10,000 ultrasound examinations is the same whether four or 80 defects are detected but the cost per defect falls from $476,190 to $31,250.
14 Second, infants diagnosed prenatally do not incur the high cost of neonatal transport from community hospital to a cardiac center of excellence. 15 Finally, the one-on-one guidance from the pediatric cardiologist during fetal echocardiography need not continue indefinitely. Once the obstetrical personnel have sufficient experience to accurately recognize CCHD, they can consult the pediatric cardiologist only for suspected defects, arrhythmias or congestive heart failure. Further studies are clearly needed to define the immediate and long-term costs and savings of the integrated model.
Although not specifically evaluated, this collaboration between MFM and pediatric cardiology is also likely to promote a more efficient model of care. Through such an association, both the fetal anatomic survey and cardiac exam can be performed at the same visit by the same sonographer, supervised by the MFM and the pediatric cardiologist. If an anomaly is discovered, the pregnant woman can be counseled by both the MFM and the pediatric cardiologist together and a plan for the remainder of the pregnancy, delivery, and the likely postnatal course can be outlined. Where additional testing, (e.g., amniocentesis) is desired, it can be performed at the same visit. Finally, an accurate and timely diagnosis of CCHD in the setting of an abnormal fetal karyotype or severe noncardiac abnormalities may help to guide parents who face difficult pregnancy or postnatal choices.
